Description

GABASIGN 600 CAP is a high-strength formulation of Gabapentin 600 mg, an antiepileptic and analgesic agent prescribed for managing partial seizures, postherpetic neuralgia, diabetic neuropathy, and various other neuropathic pain syndromes.

Gabapentin works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the nervous system. This reduces the release of excitatory neurotransmitters and dampens the transmission of pain signals, offering relief in chronic neurological disorders.

Ideal for moderate to severe conditions, GABASIGN 600 CAP is often used when lower doses (100–400 mg) are insufficient to provide optimal therapeutic results.

Therapeutic Uses:

• Partial-onset seizures in adults and children (adjunctive therapy)

• Postherpetic neuralgia (nerve pain following shingles)

• Diabetic neuropathy (nerve damage due to diabetes)

• Chronic nerve-related pain (fibromyalgia, spinal cord injury)

• Restless leg syndrome (off-label)

Key Benefits:

• Higher dosage for enhanced pain control and seizure management

• Suitable for chronic, long-term neurological conditions

• Low abuse potential compared to opioids

• Better tolerability with gradual titration

• Manufactured under WHO-GMP and ISO standards

GABASIGN 600 CAP is produced in certified pharmaceutical facilities and globally distributed by BLUEPILL EXPRESS, known for its quality assurance, compliance support, and reliable export network across Asia, Europe, Africa, Latin America, and the Middle East.